Office of Medical and Scientific Justice – FDA Failures Continue to Put Patients at Risk
In 1957, the Upjohn Company launched the antibiotic Panalba. The drug was administered to thousands of Americans for more than a decade. By 1968, Panalba sales totaled $18 million. After years of complaints related to the drug, FDA Commissioner , reported that roughly one in five patients who received it suffered a …